BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor trial: could adding radiation to targeted therapy and immunotherapy improve outcomes?
Disease control OngoingThis study is for people with a specific type of melanoma (BRAF V600 mutation) that has spread to the brain. It tests whether adding a precise form of radiation (stereotactic radiosurgery) to a combination of targeted drugs (binimetinib and encorafenib) and an immunotherapy (pemb…
Matched conditions: BRAF V600 MUTATION
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 02, 2026 11:40 UTC
-
Scientists hunt for hidden genetic clues behind lung cancer drug resistance.
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers become resistant to targeted drugs called tyrosine kinase inhibitors (TKIs). Researchers will analyze tumor tissue from 40 patients whose cancer has stopped responding to treatment. They hope to find new genetic changes that cause resi…
Matched conditions: BRAF V600 MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 03, 2026 12:02 UTC